Shots: Study involves assessing of inhaled TLR9 agonist with anti-PD-1 in mouse preclinical model, leading a long term survival in two different mouse lung tumour models Administration of SD-101 in lungs of mice with metastatic tumours results in ~90% reduction in tumour burden in lung and liver both enhancing survival time and survival rate of […]Read More
